Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF vs TDF in Early and Middle Pregnancy Antiviral Therapy for Chronic Hepatitis B
NCT07542951Phase 4Enrolling by invitation
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Started Dec 2024; status: enrolling by invitation.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07542951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07542951.